tetano
Editor, Senior Moderator
Cureus
. 2021 May 5;13(5):e14853.
doi: 10.7759/cureus.14853.
Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration
Precious O Idogun[SUP] 1 [/SUP], Mindy C Ward[SUP] 1 [/SUP], Yeshanew Teklie[SUP] 1 [/SUP], Wilhelmine Wiese-Rometsch[SUP] 1 [/SUP], Joel Baker[SUP] 1 [/SUP]
Affiliations
Abstract
A few individuals are believed to have developed immune thrombocytopenia (ITP) following the administration of the coronavirus disease 2019 (COVID-19) vaccine. This phenomenon has been reported in a few case reports and also in some recent news articles. In this report, we discuss a case of a 54-year-old Caucasian female who presented to the emergency room with life-threatening thrombocytopenia in the setting of de novo ITP following COVID-19 vaccine administration. Due to the relapsing nature of ITP, it is unclear if the patient has achieved complete remission of the disease.
Keywords: adverse event; covid 19; itp; thrombocytopenia; vaccination.
. 2021 May 5;13(5):e14853.
doi: 10.7759/cureus.14853.
Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration
Precious O Idogun[SUP] 1 [/SUP], Mindy C Ward[SUP] 1 [/SUP], Yeshanew Teklie[SUP] 1 [/SUP], Wilhelmine Wiese-Rometsch[SUP] 1 [/SUP], Joel Baker[SUP] 1 [/SUP]
Affiliations
- PMID: 34113494
- PMCID: PMC8176657
- DOI: 10.7759/cureus.14853
Abstract
A few individuals are believed to have developed immune thrombocytopenia (ITP) following the administration of the coronavirus disease 2019 (COVID-19) vaccine. This phenomenon has been reported in a few case reports and also in some recent news articles. In this report, we discuss a case of a 54-year-old Caucasian female who presented to the emergency room with life-threatening thrombocytopenia in the setting of de novo ITP following COVID-19 vaccine administration. Due to the relapsing nature of ITP, it is unclear if the patient has achieved complete remission of the disease.
Keywords: adverse event; covid 19; itp; thrombocytopenia; vaccination.